Clinical Trials Browser

Interventional × Urologic Neoplasms × Docetaxel × Clear all

NCT03636256 2023-08-14

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Phase 1/2 Completed

36 enrolled 18 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urogenital Neoplasms, Urologic Neoplasms

NCT01155791 2017-03-15

Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms, Urologic Neoplasms